CLL Global Research Foundation began as a concept from patients with chronic lymphocytic leukemia (CLL). The idea was to provide a spotlight on CLL and to accelerate CLL research. Therefore, CLL Global is committed to accelerating progress towards the control of CLL and ultimately finding a cure for the disease as quickly as possible. To accomplish this, we promote a novel structure for research. We preferentially fund projects that translate into rapid clinical applications. We pride ourselves in complementing, rather than replacing, other funding mechanisms by accelerating new ideas, which allows researchers the opportunity for increased funding from other resources.
The CLL Society Inc. is a patient–centric, physician–curated nonprofit organization focused on patient education, support and research. Dedicated to addressing the unmet needs of the CLL and related blood cancer communities, we explain the rapidly changing therapeutic landscape and the importance of clinical trials, support and build patient networks, engage in research and educate providers and patients.
The Leukemia & Lymphoma Society (LLS) is the world's largest voluntary health agency dedicated to blood cancer. The LLS mission is to cure leukemia, lymphoma, Hodgkin's disease myeloma and myeloproliferative neoplasms and to improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world and provides free information and support services, including financial support and talking to an information specialist.
Cancer Support Community (CSC) is dedicated to ensuring that all people impacted by cancer are empowered by knowledge, strengthened by action, and sustained by community. This global network of 175 locations, including CSC and Gilda's Club centers, healthcare partnerships, and satellite locations that deliver more than $50 million in free support services to patients and families. In addition, CSC administers a toll-free helpline and produces award-winning educational resources that reach more than one million people each year.